Literature DB >> 25290404

The non-MHC transplantation antigens: neither weak nor minor.

B Loveland1, E Simpson.   

Abstract

The existence of minor histocompatibility (mH) antigens is implied by the very naming of the major histocompatibility antigens. Grafts exchanged between individuals matched at the major histocompatibility complex (MHC) (which encodes the antigens that produce rapid graft rejection) are rejected, albeit at a somewhat slower pace than MHC grafts. There are multiple mH antigen differences between MHC (HLA) matched humans and between MHC (H-2) identical mouse strains. Using mH congenic mouse strains, however, individual mH antigens can be studied, and these provide a basis for interpretation of immune responses to multiple mH antigens in HLA matched human grafts. In this article Bruce Loveland and Elizabeth Simpson discuss four aspects of mH antigens: their immunogenicity; immune response (Ir) gene regulation; mH antigens in man; and recent models which might lead to their molecular identity.
Copyright © 1986. Published by Elsevier B.V.

Entities:  

Year:  1986        PMID: 25290404     DOI: 10.1016/0167-5699(86)90109-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  9 in total

1.  Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.

Authors:  T Wölfel; A Van Pel; E De Plaen; C Lurquin; J L Maryanski; T Boon
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.

Authors:  H G Rammensee; H Schild; U Theopold
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 3.  Cultivation of human keratinocyte stem cells: current and future clinical applications.

Authors:  G Pellegrini; S Bondanza; L Guerra; M De Luca
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

4.  Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

Authors:  C A van Els; J D'Amaro; J Pool; E Blokland; A Bakker; P J van Elsen; J J van Rood; E Goulmy
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Evaluation of in vitro cytotoxic T lymphocyte assays as a predictive test for the occurrence of graft vs host disease.

Authors:  P Fontaine; J Langlais; C Perreault
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice.

Authors:  H Widner; P Brundin; A Björklund; E Möller
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.

Authors:  Sahil Shah; Saeed Daneshmandi; Kevin R Hughes; Shuangjin Yu; Angela M Bedoya; Lonnie D Shea; Xunrong Luo
Journal:  Biomaterials       Date:  2019-05-01       Impact factor: 12.479

8.  Prediction of graft-versus-host disease in humans by donor gene-expression profiling.

Authors:  Chantal Baron; Roland Somogyi; Larry D Greller; Vincent Rineau; Peter Wilkinson; Carolyn R Cho; Mark J Cameron; David J Kelvin; Pierre Chagnon; Denis-Claude Roy; Lambert Busque; Rafick-Pierre Sékaly; Claude Perreault
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

Review 9.  Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis.

Authors:  H Widner; P Brundin
Journal:  Brain Res       Date:  1988-11       Impact factor: 3.252

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.